FDMT NASDAQ
4D Molecular Therapeutics, Inc.
1W: -11.4%
1M: -11.3%
3M: -3.7%
YTD: +18.7%
1Y: +125.7%
3Y: -51.4%
5Y: -67.2%
$8.60
-0.09 (-1.04%)
Weekly Expected Move ±9.2%
$7
$8
$9
$10
$11
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$88M
Revenue
+383560.9% YoY
$-161M
Net Income
+8.8% YoY
$-130M
Free Cash Flow
+17.1% YoY
32.6%
Gross Margin
-2416.1%
Op. Margin
-2256.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-31.7%
ROA-28.6%
ROIC-114.0%
Valuation
P/E-3.6
P/B1.3
EV/EBITDA-1.4
Leverage
Debt/Equity0.04
Current Ratio9.39
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z4.35
Beneish M191.94